| HOME >> BIOLOGY >> TECHNOLOGY |
The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.
CONTACT: Amgen, Thousand Oaks
Christine Regan: 617-359-1324 or 805-447-5476 (media)
Arvind Sood: 805-447-1060 (investor
'/>"/>
| SOURCE Amgen Copyright©2008 PR Newswire. All rights reserved |